Skip to main content
Frontiers in Cellular and Infection Microbiology logoLink to Frontiers in Cellular and Infection Microbiology
. 2026 Jan 5;15:1702430. doi: 10.3389/fcimb.2025.1702430

Correction: SARS-CoV-2 exploits steroidogenic machinery, triggers lipid metabolism for viral replication and induces immune response in Leydig cells of K18-hACE2 mice

Salmo Azambuja de Oliveira 1, André Acácio Souza da Silva 1, Barry T Hinton 2, Giovanni Freitas Gomes 3, Thiago Mattar Cunha 3, Paulo Sérgio Cerri 4, Estela Sasso-Cerri 4,*
PMCID: PMC12814913  PMID: 41561079

In the published article, Figure 4F was retouched to eliminate three artifacts from toluidine blue staining. These artifactual blue deposits were retouched for aesthetic purposes, and the retouching does not impact the interpretation of the data nor the conclusions of the study.

Figure 4.

Histological images depict cellular structures with annotations indicating seminiferous tubules (ST), interstitial tissue (IT), and various cellular markers in control (CG) and induced groups (IG). Panels 4A and 4B compare tissue organization; 4C and 4D highlight cellular differences with arrows; 4E and 4F show Leydig cells with magnified insets. Charts 4G to 4J display quantitative data on nuclear area and mRNA expression levels for different genes, comparing CG and IG groups.

(A–F) Photomicrographs of testicular sections of animals from CG and IG stained with H.E. (A-D), and semithin sections stained with toluidine blue (E, F). In (A), normal histoarchitecture of the seminiferous tubules (ST) and interstitial tissue (IT) is observed in CG. However, in (B) (IG), intraepithelial spaces are seen in the seminiferous tubules (ST; stars). IT, interstitial tissue. In (C), the interstitial tissue exhibits typical LCs with round/ovoid nucleus (thick arrows) whereas in (D), these cells show irregular and reduced nucleus (thick arrows), and numerous lipid inclusions (asterisks) in comparison to CG. In (E, F), semithin sections show interstitial tissue containing macrophages (thin arrows) and LCs (thick arrows). Numerous and large lipid inclusions (asterisks) are observed in the LCs of IG when compared to CG. Note the spirally arranged cisternae in these cells (insets; arrowheads). (G) Significant reduction of LC nuclear area is observed in IG in comparison to CG. (H–J) A significant increase in the mRNA expression of Srebp1, Dgat-1 and Scarb1 is observed in IG when compared to CG. *p value.

The original figure is illustrated below.

In the published article, there were errors in Table 1.

Table 1.

Primary and secondary antibodies.

Antibody name Dilution Catalog number Manufacturer RRID
Mouse anti-ACE2 monoclonal antibody 1:50 sc-73668 Santa Cruz Biotechnology, USA AB_2861379
Rabbit anti-SARS-CoV-2 Spike Protein S1 Recombinant monoclonal antibody 1:250 MA5-36247 Invitrogen by Thermo Fisher Scientific AB_2890589
Rabbit anti-SARS-CoV-2 nucleocapsid protein monoclonal antibody 1:3000 ab271180 Abcam, Cambridge, UK
Rabbit anti-IL-1β polyclonal antibody 1:400 ab9722 Abcam, Cambridge, UK AB_308765
Goat anti-IL-6 (M19) polyclonal antibody 1:400 sc-1265 Santa Cruz Biotechnology, USA AB_2127470
Mouse anti-TNF-α monoclonal [52B83] antibody 1:200 ab1793 Abcam, Cambridge, UK AB_302615
Rabbit anti-CD163 monoclonal antibody 1:100 ab182422 Abcam, Cambridge, UK AB_2753196
Rabbit anti-CD68 polyclonal antibody 1:100 ab125212 Abcam, Cambridge, UK AB_10975465
Rabbit anti-17β-HSD6 polyclonal antibody 1:500 sc-393936 Santa Cruz Biotechnology, USA AB_2891064
Rabbit anti-StAR polyclonal antibody 1:1000 PAS-95765 Invitrogen by Thermo Fisher Scientific
Mouse anti-testosterone polyclonal antibody 1:100 ab217912 Abcam, Cambridge, UK AB_308765
Rabbit anti-IL-10 polyclonal antibody 1:500 sc-8438 Santa Cruz Biotechnology, USA AB_627793
Rabbit anti-MIF polyclonal antibody 1:200 251415 ABBIOTEC, USA AB_10636927
Rabbit anti-β-tubulin monoclonal antibody 1:8000 ab108342 Abcam, Cambridge, UK AB_10866289
HRP-conjugated anti-rabbit secondary antibody 1:9000 A9169 Sigma-Aldrich, USA
Alexa Fluor®488 anti-mouse antibody 1:1000 ab150113 Abcam, Cambridge, UK AB_2576208
Alexa Fluor®488 anti-rabbit antibody 1:1000 ab150077 Abcam, Cambridge, UK AB_2630356
Alexa Fluor®594 anti-mouse antibody 1:1000 ab150116 Abcam, Cambridge, UK AB_2650601
Alexa Fluor® 647 anti-rabbit antibody 1:1000 ab150075 Abcam, Cambridge, UK AB_2752244
Alexa Fluor®647 anti-goat antibody 1:1000 ab150135 Abcam, Cambridge, UK AB_2687955

The antibody “Donkey anti IL-6 (M19) polyclonal antibody” is incorrect. The actual antibody used was “Goat anti-IL-6 (M19) polyclonal antibody”. The “mouse anti-17beta-HSD7 antibody; 1:500 sc-393936; Santa Cruz Biotechnology, USA AB_2891064” is incorrect. The actual antibody used was the “Rabbit anti-17beta-HSD6; 2μg/ml; sc-101878; Santa Cruz Biotechnology, USA”. Regarding Alexa Fluor® 488 anti-mouse antibody, the “catalog number (A11001), manufacturer (Molecular Probes by Life Technologies) and RRID” are incorrect. The correct is “catalog number ab150113; manufacturer (Abcam, Cambridge, UK) and RRID (AB_2576208)”. The data regarding the “Alexa Fluor® 594 anti-rabbit antibody” are incorrect. The correct is “Alexa Fluor® 647 anti-rabbit antibody; dilution 1:1000, catalog number (ab150075); manufacturer (Abcam, Cambridge, UK); RRID (AB_2752244)”. The “Alexa Fluor® 647 anti-donkey polyclonal antibody” is incorrect. The correct is “Alexa Fluor® 647 anti-goat antibody; dilution 1:1000; RRID (AB_2687955)”. The “Alexa Fluor® 488 anti-rabbit antibody, Alexa Fluor® 594 anti-mouse antibody, and their respective dilution, catalog number, manufacturer and RRID” were missing and were added to Table 1. The corrected Table 1 is below.

Methods (items 2.6 - page 4 and 2.7 -page 5), where it reads “17beta-HSD7”, the correct word is “17beta-HSD6”; this was incorrectly described by mistake.

A correction has been made to the sections:

2. Material and methods, 2. 6 Immunohistochemistry and immunofluorescence analyses, Paragraph 2, Line 9: “anti-17β-HSD6 polyclonal antibody”

2.7 Double immunofluorescence analysis, Lines 4-11:

“Moreover, to confirm if the LCs express an inflammatory profile, double immunofluorescences for detection of 17β-HSD6+IL-6, 17β-HSD6+IL-1β and StAR+TNF-α were also performed. The double immunofluorescence reactions were performed according to de Santi et al. (2022). After antigen recovery, the sections were incubated overnight at 4°C with the following primary antibodies (Table 1): anti-human ACE2 monoclonal antibody, anti-17β-HSD6 polyclonal antibody or anti-StAR polyclonal antibody.”

Legend: Figure 1 (J, K): where it reads “17beta-HSD7”, the correct word is “17beta-HSD6”.

The original version of this article has been updated.

Footnotes

Edited and reviewed by: Katarzyna Otulak-Kozieł, Warsaw University of Life Sciences, Poland

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Cellular and Infection Microbiology are provided here courtesy of Frontiers Media SA

RESOURCES